2023 Biotech Outlook Call Series

Expert Call Schedule

The following calls are part of the Oppenheimer 2023 Kick-off Biotech Outlook Call Series. To inquire about additional information in regards to the calls within this series, please contact your Oppenheimer sales representative.

Agenda as of 1/26/23

Monday, January 23, 2023 | 2:00 PM ET

Expert Call: How Might New Targets in IgAN Change Management of Glomerulopathies?

Analyst Host: Justin Kim, Senior Research Analyst & Executive Director, Biotechnology

Wednesday, January 25, 2023 | 1:00 PM ET

Expert Call: Ushering in 2023 with Potential Treatments for Geographic Atrophy

Oppenheimer Host: Justin Kim, Senior Research Analyst & Executive Director, Biotechnology

Thursday, January 26, 2023 | 12:00 PM ET

Expert Call: Deep Dive into AVDL’s Lumryz (once-nightly oxybate) for Narcolepsy

Oppenheimer Host: Francois Brisebois, Senior Research Analyst & Managing Director, Biotechnology

Friday, January 27, 2023 | 1:00 PM ET

Expert Call: AML – Current Treatments and Future Directions

Oppenheimer Host: Matthew Biegler, Senior Research Analyst & Executive Director, Emerging Biotechnology

Monday, January 30, 2023 | 1:00 PM ET

Expert Call: The Future of Myelofibrosisy

Oppenheimer Host: Jay Olson, CFA, Senior Research Analyst & Managing Director, Biotechnology

Tuesday, January 31, 2023 | 11:00 AM ET

Expert Call: Treatment of IPF and Highlights From Recent Clinical Studies

Analyst Host: Jeff Jones, PhD, Senior Research Analyst & Managing Director, Biotechnology

Wednesday, February 1, 2023 | 10:00 AM ET

Expert Call: Recurrent C. difficile Infection

Oppenheimer Host: Mark Breidenbach, PhD, Senior Research Analyst & Managing Director, Emerging Biotechnology

Friday, February 3, 2023 | 11:00 AM ET

Expert Call: Therapeutics for Cardiovascular Disorders

Oppenheimer Host: Leland Gershell, MD, PhD, Senior Research Analyst & Managing Director, Biopharmaceuticals

Friday, February 3, 2023 | 12:00 PM ET

Expert Call: Treatment Landscape and Emerging Treatment Options in Pain

Oppenheimer Host: Hartaj Singh, Senior Research Analyst & Managing Director, Biotechnology

For institutional investors only.
Please contact your Oppenheimer institutional sales representative for more information.